Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FluoGuide publish the presentation of FG001 results from the first clinical trial in aggressive brain cancer

Copenhagen, Denmark, 23 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the presentation of the results from the clinical trial of FG001 used to guide surgery in patients with aggressive high-grade glioma brain cancer, can be accessed on the company’s homepage via https://fluoguide.com/investor/presentations/As a follow-up on the award-winning presentation done by Principal Investigator and Chief Surgeon Jane Skjøth-Rasmussen at the 68th Scandinavian Neurosurgical Society (SNS) Congress held 14-16 May 2022, in Bergen, Norway, FluoGuide held a company

Scania and Einride sign deal to accelerate electrification of road freight with fleet of 110 trucks

The 110 trucks marks the largest order of heavy duty electric trucks to date for Scania, kicking off a collaborative product development partnership with Einride.The Swedish freight technology company Einride, a leading provider of end-to-end digital, electric and autonomous shipping solutions, will begin the roll out of 110 Scania trucks starting in the second half of 2022. Einride already has one of Europe’s largest heavy duty electric fleets, and will further expand their market presence with this partnership.  The full fleet of trucks will be built to Einride's hardware

Fazer plans to locate its new confectionery factory in Lahti, Finland

Fazer has signed a co-operation agreement with the city of Lahti regarding the reservation of a land plot in the industrial area of Pippo-Kujala for the planned confectionery factory. The co-operation agreement is part of the basic design phase of the factory and precedes the actual property transaction and the investment decision, which can be expected in the first half of 2023. If realised, the new confectionery factory would replace the existing factories in Vantaa and Lappeenranta. Operations would transfer gradually to the new factory during the years 2025-2027.Fazer’s strategic

Volvo Car AB: Contemplating new green bond issuance

Volvo Car AB (publ) has mandated BofA Securities, Credit Agricole CIB, Deutsche Bank and HSBC as Joint Active Bookrunners, to arrange a series of fixed income investor calls on 23 of May 2022. A Reg S, senior unsecured, EUR-denominated fixed-rate €500m will-not-grow 6-year Green bond issued under Volvo Car AB’s EMTN programme guaranteed by Volvo Car Corporation may follow, subject to market conditions. The Green bond will be issued in accordance with the company's Green Financing Framework dated September 2020, and a second party opinion (“SPO”) rated Dark Green has been issued by CICERO,

Kemira Oyj: Change in the holding of the company’s own shares

Kemira Oyj, Stock Exchange Release, May 23, 2022 at 11.15 am (EEST)Kemira Oyj: Change in the holding of the company’s own shares  On May 23, 2022 a total of 1,496 shares have been returned to Kemira Oyj.   The return is related to the share issues announced on March 4, 2021 . In the share issue, Kemira shares held by the company were conveyed to key employees participating in the share incentive plan during the 2020 performance period. The shares were returned to the

Wärtsilä to partner with Capwatt in green hydrogen blending project in Portugal

Wärtsilä Corporation, Press release, 23 May 2022 at 11:00 AM EESTThe technology group Wärtsilä will collaborate with the Portuguese energy solutions provider and independent power producer Capwatt in the testing of a green hydrogen and natural gas blend fuel for Capwatt power plant located in Maia. The project will start in Q1, 2023 and it aims at testing blends of up to 10 vol.% green hydrogen. The combined heat and power plant which provides energy for Sonae  Campus and the national grid currently operates with a Wärtsilä 34SG engine running on natural gas. This

SimCorp A/S – Share buyback program

Company Announcement no. 24/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

Construction company Q-gruppen and Caverion continue their partnership – next project at Barkaby Station in Stockholm

Caverion Corporation Press release 23 May 2022 at 11.00 a.m. EESTConstruction company Q-gruppen and Caverion continue their partnership – next project at Barkaby Station in Stockholm Caverion and construction company Q-gruppen have signed an agreement for the construction of the Barkarby Station “Northern Entrance” in Stockholm, Sweden. Caverion is responsible for the technical installation of automation, security, electricity and information and telecommunications solutions in the project, which runs from May 2022 to November 2025. The end customer is the Swedish Transport

Riksbank launches service for instant payments

Today the RIX-INST service is launched, which means that payments between banks can be made in real time 24 hours a day and 365 days a year in central bank money. The Riksbank is thus offering the banks a secure and cost-effective payment system for instant payments that creates opportunities for Swedish companies to develop new innovative payment services. The service is connected to the Eurosystem payment platform, TIPS.Instant payments, when bank customers move money from one bank to another in just seconds, are becoming increasingly common. Sweden is already one of the world’s most

Ilya Pharma extends global patent coverage for ILP100 for the treatment of diseases of skin and mucosa in humans and animals

Low manufacturing costs, excellent temperature stability and high efficacy attracting increasing attentionUppsala, May 23, 2022: Ilya Pharma (the Company), a clinical stage immunotherapy company today announced that the Indian Patent Office (IPO) has issued the Company Patent No 395551 titled “Methods for Wound Healing”. The patent covers the general use of a plasmid capable of expressing the protein CXCL12 in L. reuteri. The modified bacteria may be used for treatment of both mucosal and cutaneous wounds in humans and animals. These claims protect inventions which are central to the

BLAST and Dansk Industri team up to support growth of esports industry in Denmark

Esports entertainment company BLAST and Dansk Industri (DI) will team up to support the long-term development of esports and establish a unified voice for the industry in Denmark.BLAST and DI will work together to help shape and support a framework to develop and further cement Denmark’s status as a leader in esports, an industry that is now valued at over a billion dollars and is on course to have a global esports viewership of 577 million by 2024.  Denmark has an illustrious history in esports, and has grown to become one of the most dominant esports nations in the world. The country

BioStock Studio: An in-depth look at Ultimovacs' cancer vaccine

The field of immuno-oncology is growing, and cancer vaccines are a big part of that. Norwegian biotech Ultimovacs is developing its own cancer vaccine technology platform. BioStock invited Sara Mangsbo, Chief Innovation Officer at Ultimovacs, to the Studio to learn more.Watch the interview with Sara Mangsbo at biostock.se : https://www.biostock.se/en/2022/05/an-in-depth-look-at-ultimovacs-cancer-vaccine/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

SmartCraft ASA (SMCRT) - Invitation to presentation of first quarter 2022 results

SmartCraft ASA | Non-regulatory press releases 23 May 2022 – SmartCraft ASA will publish its first quarter 2022 financial report on Tuesday 24 May 2022 at 07:00 CET together with the Q1 2022 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report on the same day, Tuesday 24 May 2022, at 08:00 CET. Webcast link:https://channel.royalcast.com/landingpage/hegnarmedia/20220524_1/ Presenters: Chief Executive Officer Gustav Line, Chief Financial Officer Kjartan

BioStock: Aptahem signs agreement with CRO for phase I studies

Aptahem has entered into an agreement with a clinical contract research organisation in the Netherlands for the implementation of the upcoming phase I sepsis study with the drug candidate Apta-1. The news followed the earlier announcement that Aptahem has joined a new research consortium that will evaluate novel treatments to reduce inflammation in cardiovascular diseases and breast cancer, again focusing on Apta-1.Read the full article at biostock.se: https://www.biostock.se/en/2022/05/aptahem-signs-agreement-with-cro-for-phase-i-studies/ This is a press release from BioStock -

9 Trees, 1 Aim for Chelsea Flower Show.

9trees to help RHS members balance their carbon footprint.Chelsea, London. Monday 23rd May 2022. For immediate release. Powys based 9Trees is honoured to be a guest of Harrison Ovens who’s stand at this year’s RHS Chelsea Flower Show has been designed by award-winning designer Sarah Morgan founder of The Garden Creative Featuring three native trees Birch, Hazel & Elder (Betula Pendula, Crataegus Monogyna and Sambucus Nigra). 9Trees usually plants up to 15 different types of trees in their new woodlands. Creating a rich diversity for wildlife and wellbeing, not profit. One of

Loughton Contracts saves £250,000 a year with Medius’s accounts payable technology

UK’s leading flooring contractor introduced automated payments for 2,000-3,000 monthly invoices following the pandemicLONDON, May 23, 2022 - Loughton Contracts has announced that it selected Medius , a leading provider of Accounts Payable automation and wider spend management solutions, to help the company move from a manual, paper-based invoice process, to a digital, paperless system.  Loughton Contracts processes 2,000 to 3,000 invoices every month, with the payment of invoices to suppliers and contractors sitting right at the heart of the business. With

NCC to build a new school for 850 students in Finland

NCC has been commissioned by the city of Mikkeli to build the Saimaanportti school in Finland. The project is a turnkey contract, and the order value is approximately SEK 270 million. The school encompasses approximately 62,000 square meters and will accommodate 850 students from grades 1 through 9. NCC’s assignment also includes the construction of a sports hall, gym and schoolyard. The building will be built out of wood and concrete and has been designed to be a supportive and healthy learning environment with many different educational opportunities in the same building. “

BioStock:Targinta takes lead in the ADC field in the Nordics

Targinta has selected the first ADC drug candidate, TARG9, which is armed with a powerful toxin, primarily for the treatment of triple-negative breast cancer and glioblastoma. With this, the company is established as a leading player in the Nordics in the field of so-called antibody-drug conjugates. BioStock dives deep into the potential and benefits of the ADC technology.Read the full article at biostock.se : https://www.biostock.se/en/2022/05/targinta-takes-lead-in-the-adc-field-in-the-nordics/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states

LUND, SWEDEN – The Pennsylvania and Maryland Departments of Health have granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical Laboratory permits, allowing physicians in Pennsylvania and Maryland to order the IMMray™ PanCan-d test for their patients.   “Many clinicians in Pennsylvania and Maryland have been at the forefront of efforts to enhance surveillance for pancreatic cancer. We are very happy that these physicians can now utilize IMMray™ PanCan-d to detect pancreatic cancer in at-risk patients at stages 1 and 2. With these permits, we are

Cantargia publishes interim report for first quarter 2022

Cantargia AB’s (”Cantargia”) interim report for first quarter 2022 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the first quarter · Clinical development of nadunolimab in pancreatic cancer (PDAC) was advanced by including nadunolimab in Pancreatic Cancer Action Network’s (PanCAN) phase II/III clinical trial Precision Promise℠. · The first patient with non-squamous non-small cell lung cancer (NSCLC) was treated in a new arm in CANFOUR, and the first patient with triple-negative breast cancer was treated in the

HODL SPAC Europe AB: Interim report for the first quarter 2022

HODL SPAC Europe AB (publ) hereby publishes the interim report for the period January – March 2022.  The interim report is available as an attached document and on the company's website (www.hodlspac.se). Below is a summary of the report.”Today's market climate clarifies some of the benefits of a listing via a SPAC. Since the listing in January, we have met with a large number of companies that work with blockchain, and there are many companies of good quality."  - Vahid Toosi, CEO First quarter 2022 · Earnings per share amounted to SEK -0.04 (--). · Profit after tax amounted to

The Board of Directors of Haldex AB (publ) withdraws proposal of confirmation of allotment under 2021 LTI

The Board of Directors of Haldex AB (publ) has decided to withdraw the previously communicated proposal to the Annual General Meeting 2022 of confirmation of allotment under the incentive program for the CEO which was approved by the Annual General Meeting 2021 (“2021 LTI”).The 2021 LTI gave the CEO the right to, under certain conditions, acquire Haldex shares against a pre-defined strike price (the “Options”). For participation in the 2021 LTI the CEO was required to own a certain number of shares in Haldex (“Qualifying Shares”). Pursuant to the terms of the 2021 LTI, the CEO were to

Akobo Minerals – First quarter 2022 results

OSLO, 23 May 2022: Akobo Minerals AB (publ) (EURONEXT: AKOBO) today reported its first quarter 2022 results. Akobo Minerals is still in a project development phase and consequently had no income in the first quarter. The net loss for the period was SEK 0.373 million, affected by positive foreign exchange effects. The company has no external debt and a strong cash position of SEK 21 million.   Jørgen Evjen, CEO of Akobo Minerals, said: “The first quarter of 2022 proved to be a very positive start to the year, with many highlights. Our exploration team has been effective in completing

There are no items matching the current filter
There are no more items matching the current filter
Back to top